Trial Profile
The Sumatriptan and Naratriptan Pregnancy Registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2023
Price :
$35
*
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary) ; Naratriptan (Primary) ; Sumatriptan (Primary)
- Indications Migraine
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 14 Nov 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Nov 2011 Planned patient number is 1 according to ClinicalTrials.gov.
- 06 Feb 2010 New trial record